You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Small UAS compatible Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) Sensors
SBC: NEVADA NANOTECH SYSTEMS, INC. Topic: AF18BT009This project will demonstrate a proof-of-concept Small Unmanned Aerial System (SUAS) equipped with chemical sensors for plume tracking and source detection in a realistic outdoor environment. The project will first develop designs for incorporating chemical sensors onto Group 1 fixed wing and quadcopter SUAS, then make SUAS-performance-enhancing improvements to the Molecular Property Spectromete ...
STTR Phase II 2021 Department of DefenseAir Force -
Composite-Integrated Electrical Networks for Endurance-Optimized Airframes
SBC: Nautilus Defense LLC Topic: AFX20DTCSO1By integrating conductors into composite structures, data and power networks can become part of the vehicle’s airframe, allowing for size, weight, and assembly savings and improved mission endurance. During the proposed effort, project team members Nautilus Defense, The University of Rhode Island, and Goetz Composites seeks to validate the structural and electrical performance of these compo ...
STTR Phase I 2021 Department of DefenseAir Force -
Development of a Digital Cognitive Screening Test to detect Mild Cognitive Impairment and Dementia in Clinical Settings.
SBC: EchoWear LLC Topic: NIAProject Summary Alzheimer’s disease and related dementias are a growing health problem in our aging population. Assessment of cognitive functioning for early detection is critical to identify individuals who might benefit from treatment with the available symptomatic medications for mild dementia as well as future disease-modifying therapies that are actively under development and being tested i ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Promoting adult hippocampal neurogenesis in Alzheimer's Disease using an antibody-based therapy
SBC: BOLDEN THERAPEUTICS, INC. Topic: RPROJECT SUMMARY Alzheimer's disease (AD) is a looming public health crisis that threatens millions of patients' ability to experience healthy aging. In addition to the challenges that AD poses to patients, healthcare providers and caregivers, there is also tremendous economic burden associated with AD and related dementias – estimated to be well over $200B/year in the United States alone. Hundre ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
SnapCap: a device to decontaminate central venous catheters (CVC) with 5 snaps
SBC: Contech Medical, Inc. Topic: NICHDProject Summary/Abstract We propose a new approach to the decontamination of central venous catheters and the prevention of central line-associated bloodstream infections (CLABSI), an important healthcare-associated infection. CLABSIs cost the US healthcare system approximately $2.3 billion annually (Pronovost, NEJM, 2009). Additionally, CLABSIs can be life threatening, especially in the very youn ...
STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Prediction and Measurement of the Carbon Build-Up in Film-Cooled Rocket Engines
SBC: SIERRA ENGINEERING, INC. Topic: AF15AT21ABSTRACT: Sierra Engineering Inc. (Sierra) believes that existing chemical kinetic models can be efficiently incorporated into commercial CFD codes to predict the mixing, pyrolysis, soot formation and carbon deposition within film cooled rocket engines. During this Phase I STTR effort we will demonstrate that this analysis capability is practical and that we can generate appropriate model validati ...
STTR Phase I 2015 Department of DefenseAir Force -
Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy
SBC: STRYKAGEN CORPORATION Topic: NIAMSDESCRIPTION provided by applicant Duchenne muscular dystrophy is caused by mutations in the dystrophin gene resulting in the loss of the dystrophin glycoprotein complex in skeletal muscle Loss of dystrophin results in reduced sarcolemmal integrity progressive muscle damage and compromised muscle function There is currently no cure and limited treatment options for DMD and all affected child ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Galectin 1: A novel small protein therapy for Duchenne muscular dystrophy
SBC: STRYKAGEN CORPORATION Topic: NIAMSDESCRIPTION provided by applicant Duchenne Muscular Dystrophy DMD is a fatal muscle disease affecting in every male births DMD results from mutations in the gene encoding the dystrophin a kDa scaffolding protein responsible for providing a mechanical link between the muscle fiber actin cytoskeleton and a transmembrane protein complex called the dystrophin associated glycoprotein ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Identification of Borrelia burgdorferi diagnostic biomarkers in humans and nonhum
SBC: DXDISCOVERY INC Topic: NIAIDDESCRIPTION provided by applicant The number of Lyme disease cases in the US has been recently estimated by the CDC at cases year This is major public health concern Currently available diagnostics rely on detection of the antibody response serology to Borrelia burgdorferi the causative agent of Lyme disease However serological tests are not accurate during the early stages of Ly ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Generation of Human Hepatocytes
SBC: IN VIVO TECHNOLOGIES Topic: N/ADESCRIPTION (provided by applicant): The goal of this project is to produce "humanized" livers in large animal models such as sheep and pigs that can serve as a reliable source of significant numbers of functional human hepatocytes. The isolated human hepatocytes and/or "humanized" livers can be used for drug toxicity studies as well as for possible clinical use in patients with liver failure. Tra ...
STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health